Abstract
The α-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid (AMPA) receptors are a family of glutamate ion channels of considerable interest in excitatory neurotransmission and associated disease processes. Here, we demonstrate how exploitation of the available X-ray crystal structure of the receptor ligand binding domain enabled the development of a new class of AMPA receptor positive allosteric modulators (7) through hybridization of known ligands (5 and 6), leading to a novel chemotype with promising pharmacological properties.
Original language | English |
---|---|
Journal | ACS Medicinal Chemistry Letters |
Early online date | 11 Feb 2015 |
DOIs | |
Publication status | Published - 2015 |
Keywords
- AMPA receptor
- structure based drug design
- hybridization
- electrophysiology